About Methuselah Health
Methuselah Health is a company based in Babraham (United Kingdom) founded in 2015 was acquired by RxCelerate in November 2022. The company has 3 employees as of September 30, 2021. Methuselah Health offers products and services including ProQuant. Methuselah Health operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.
- Headquarter Babraham, United Kingdom
- Employees 3 as on 30 Sep, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Methuselah Health Uk Limited
- Date of Incorporation 09 Sep, 2014
- Jurisdiction CAMBRIDGE, UNITED KINGDOM
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
3
as on Sep 30, 2021
-
Acquired by
RxCelerate
(Nov 22, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Methuselah Health
Methuselah Health offers a comprehensive portfolio of products and services, including ProQuant.
Platform for quantitative analysis of proteome stability in drug research.
Funding Insights of Methuselah Health
Detailed funding history for Methuselah Health
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Methuselah Health
Methuselah Health has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include RxCelerate.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pre-clinical contract research services are offered for drug candidates.
|
Locked | Locked | Locked |
Investor details for Methuselah Health
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Methuselah Health
Investment portfolio details for Methuselah Health
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Methuselah Health
Detailed financials for Methuselah Health
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Methuselah Health Comparisons
Peer comparison for Methuselah Health
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Methuselah Health
Methuselah Health operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| Locked | Locked | Locked |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Therapeutics for rare and ultra-rare metabolic diseases are developed.
|
Detailed competitors of Methuselah Health
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Methuselah Health
Complete news archive for Methuselah Health
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Methuselah Health
Methuselah Health was founded in 2015.
Methuselah Health is headquartered in Babraham, United Kingdom. It is registered at Babraham, Cambridgeshire, United Kingdom.
As of Sep 30, 2021, the latest employee count at Methuselah Health is 3.
Methuselah Health was founded in 2015 and is based in Babraham, United Kingdom. Operations are centered in the biotechnology sector, where novel targets for treating aging-linked diseases are developed. Proteome instability in such diseases is deciphered through targeted research. Technology platforms for detecting post-translational modifications across proteins in aging are being advanced. Focus remains on human disease applications within this domain.
Methuselah Health's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
Methuselah Health offers ProQuant.
Methuselah Health has 1 investor. Key investors include RxCelerate.